Shen Qi pointed at the production line. "Our Levetiracetam has a decent market share, but the total domestic market is only worth a few hundred million yuan. I'm thinking we should convert the Levetiracetam production line into an LPJK1 production line. That would cost a lot less than building a new one from scratch."
"So LPJK1 will definitely pass Phase III trials?" Old Yan asked.
"I wouldn't dare be the least bit complacent, but I'm absolutely confident."
Shen Qi gave him a determined look, then continued, "LPJK1 has completed its animal trials. From now until the clinical trials are finished, it'll take some time. I can't guarantee LPJK1 will pass approval and make it to market. All I can say is that there's hope. Old Yan, my dad doesn't know much about manufacturing processes, so we'll have to rely on you and Old Cheng. You can start researching a plan to convert the Levetiracetam production line. Once the LPJK1 side is ready, you can get started on the conversion right away."
Old Yan looked at Old Shen and Shen Qi. "Old Cheng and I should be able to handle the technical side. I don't know anything about sales, though. I'm just asking: will we stop producing and selling Levetiracetam?"
Levetiracetam (Midazolam injection) was an intravenous anesthetic widely used in various kinds of surgery.
Although it was widely used, as Shen Qi had said, annual domestic sales of Levetiracetam totaled only a few hundred million yuan.
Compared with the number of people who took medication year-round, those who underwent surgery were few and far between. How many surgeries could one person have in a lifetime?
The market's limited size was one issue. Shen Qi's real concern was another.
Ou Beiqi Pharmaceutical didn't own a single patent for Levetiracetam. It only had